SOURCE: Niusule Biotech Corp.

August 31, 2010 08:00 ET

Niusule Biotech Corp. Announces Strategic Distribution Agreement With China's Largest Drug Chain Store China Nepstar

MONROVIA, CA--(Marketwire - August 31, 2010) -  Niusule Biotech Corp. (OTCBB: NIUS) (the Company), a fast-growing, China-based bio-pharmaceutical company focusing on animal-health products and human nutraceutical supplements, today announced that it has signed a distribution agreement with China Nepstar Chain Drugstore Ltd, China's largest retail drugstore chain based on the number of directly operated stores.

The agreement, which took effect on August 25, involves the distribution of Niusule's nutrition supplement product Gummy Bear, throughout Nepstar's 55 stores in Hangzhou. In the near future, the Company will extend its sales through Nepstar's extensive network to Shanghai, Ninbo, Tianjing and Suzhou.

"We are honored that Nepstar has chosen our Gummy Bear products to expand its fine selection of nutrition supplement products nationally," said Ms. Amy Hu, CEO of Niusule. "Their professional sales team and reputation for outstanding customer service in the drugstore industry, coupled with their years of extensive business and trade experience will be a valuable asset for the growth and the promotion of the Gummy Bear. The domestic nutrition product market for children is extremely large and we believe that the cooperation with Nepstar will be a tremendous asset as we continue to expand our footprint in the industry."

About Niusule Biotech, Corp.
Niusule Biotech Corp. is a bio-pharmaceutical company dedicated to offering high-quality pharmaceutical and nutritional supplement products to enhance both animal and human health. The Company has recently acquired a majority interest in Tianjin Behigh Pharmaceutical Co., Ltd, a veterinary drug and feed additives manufacturing company that produces injections, tablets, granules, oral solutions, powder and disinfectant for animal use. For the human product line, Niusule currently has a retail distribution network throughout China comprised of 226 outlets at high-end supermarkets and shopping malls in Zhejiang province, Shanghai and Beijing. For more information about Niusule Biotech Corp., please visit www.niusule.com.

Forward Looking Statements
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," "project," "expect" and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. Niusule Biotech Corp. does not assume any duty to publicly update or revise the material contained herein.

Contact Information

  • CONTACTS
    CORPORATE:
    Niusule Biotech Corp.
    Jeffrey Tsang
    Director
    Tel: 626-446-4688
    j.tsang@niusule.com

    INVESTOR RELATIONS:
    Strategic Growth International, Inc.
    Richard E. Cooper
    Chairman
    Jennifer K. Zimmons, Ph.D.
    Managing Director
    Tel: 212-838-1444
    rcooper@sgi-ir.com
    jzimmons@sgi-ir.com